Literature DB >> 20639912

Parkinson disease: Progress towards a molecular biomarker for Parkinson disease.

Penelope Foulds, David M A Mann, J Douglas Mitchell, David Allsop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20639912     DOI： 10.1038/nrneurol.2010.78

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients.

Authors:  Hiroaki Fukumoto; Takahiko Tokuda; Takashi Kasai; Noriko Ishigami; Hiroya Hidaka; Masaki Kondo; David Allsop; Masanori Nakagawa
Journal:  FASEB J       Date:  2010-03-25       Impact factor: 5.191

2.  Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease.

Authors:  Takahiko Tokuda; Sultan A Salem; David Allsop; Toshiki Mizuno; Masanori Nakagawa; Mohamed M Qureshi; Joseph J Locascio; Michael G Schlossmacher; Omar M A El-Agnaf
Journal:  Biochem Biophys Res Commun       Date:  2006-08-14       Impact factor: 3.575

3.  Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Martin D Curran; Mark J Gibson; Jennifer A Court; Michael G Schlossmacher; David Allsop
Journal:  FASEB J       Date:  2006-03       Impact factor: 5.191

4.  Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.

Authors:  Trey Sunderland; Gary Linker; Nadeem Mirza; Karen T Putnam; David L Friedman; Lida H Kimmel; Judy Bergeson; Guy J Manetti; Matthew Zimmermann; Brian Tang; John J Bartko; Robert M Cohen
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

5.  DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease.

Authors:  Zhen Hong; Min Shi; Kathryn A Chung; Joseph F Quinn; Elaine R Peskind; Douglas Galasko; Joseph Jankovic; Cyrus P Zabetian; James B Leverenz; Geoffrey Baird; Thomas J Montine; Aneeka M Hancock; Hyejin Hwang; Catherine Pan; Joshua Bradner; Un J Kang; Poul H Jensen; Jing Zhang
Journal:  Brain       Date:  2010-02-15       Impact factor: 13.501

6.  Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease.

Authors:  Masaaki Waragai; Jianshe Wei; Masayo Fujita; Masaaki Nakai; Gilbert J Ho; Eliezer Masliah; Hiroyasu Akatsu; Tatsuo Yamada; Makoto Hashimoto
Journal:  Biochem Biophys Res Commun       Date:  2006-05-11       Impact factor: 3.575

7.  Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Authors:  John P Anderson; Donald E Walker; Jason M Goldstein; Rian de Laat; Kelly Banducci; Russell J Caccavello; Robin Barbour; Jiping Huang; Kristin Kling; Michael Lee; Linnea Diep; Pamela S Keim; Xiaofeng Shen; Tim Chataway; Michael G Schlossmacher; Peter Seubert; Dale Schenk; Sukanto Sinha; Wei Ping Gai; Tamie J Chilcote
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

8.  Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Leanne J Cooper; Nigel J Fullwood; Mark J Gibson; Martin D Curran; Jennifer A Court; David M A Mann; Shu-ichi Ikeda; Mark R Cookson; John Hardy; David Allsop
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

9.  Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration.

Authors:  Brit Mollenhauer; Valerie Cullen; Ilana Kahn; Bryan Krastins; Tiago F Outeiro; Imelda Pepivani; Juliana Ng; Walter Schulz-Schaeffer; Hans A Kretzschmar; Pamela J McLean; Claudia Trenkwalder; David A Sarracino; Jean-Paul Vonsattel; Joseph J Locascio; Omar M A El-Agnaf; Michael G Schlossmacher
Journal:  Exp Neurol       Date:  2008-06-14       Impact factor: 5.330

Review 10.  The genetics of Parkinson's syndromes: a critical review.

Authors:  John Hardy; Patrick Lewis; Tamas Revesz; Andrew Lees; Coro Paisan-Ruiz
Journal:  Curr Opin Genet Dev       Date:  2009-05-04       Impact factor: 5.578
  10 in total
  6 in total

1.  Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.

Authors:  P G Foulds; O Yokota; A Thurston; Y Davidson; Z Ahmed; J Holton; J C Thompson; H Akiyama; T Arai; M Hasegawa; A Gerhard; D Allsop; D M A Mann
Journal:  Neurobiol Dis       Date:  2011-08-10       Impact factor: 5.996

Review 2.  The Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluid α -Synuclein Levels in Parkinson's Disease: A Meta-Analysis.

Authors:  Bo Zhou; Min Wen; Wen-Feng Yu; Chun-Lin Zhang; Ling Jiao
Journal:  Parkinsons Dis       Date:  2015-07-29

3.  Identification of α-Synuclein Proaggregator: Rapid Synthesis and Streamlining RT-QuIC Assays in Parkinson's Disease.

Authors:  Fumito Takada; Takahito Kasahara; Kentaro Otake; Takamitsu Maru; Masanori Miwa; Kei Muto; Minoru Sasaki; Yoshihiko Hirozane; Masato Yoshikawa; Junichiro Yamaguchi
Journal:  ACS Med Chem Lett       Date:  2022-08-11       Impact factor: 4.632

4.  Gene expression profiling combined with bioinformatics analysis identify biomarkers for Parkinson disease.

Authors:  Hongyu Diao; Xinxing Li; Sheng Hu; Yunhui Liu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

5.  A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease.

Authors:  Penelope G Foulds; Peter Diggle; J Douglas Mitchell; Angela Parker; Masato Hasegawa; Masami Masuda-Suzukake; David M A Mann; David Allsop
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 6.  Potential Role of Epigenetic Mechanism in Manganese Induced Neurotoxicity.

Authors:  Prashant Tarale; Tapan Chakrabarti; Saravanadevi Sivanesan; Pravin Naoghare; Amit Bafana; Kannan Krishnamurthi
Journal:  Biomed Res Int       Date:  2016-05-26       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.